Fiduciary Alliance’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.37M Buy
27,510
+20,201
+276% +$1.78M 0.18% 131
2026
Q2
$572K Sell
7,309
-329
-4% -$26.5K 0.04% 343
2026
Q1
$665K Buy
7,638
+223
+3% +$21.4K 0.04% 326
2025
Q4
$712K Sell
7,415
-240
-3% -$23.3K 0.05% 289
2025
Q3
$729K Sell
7,655
-466
-6% -$42.8K 0.05% 277
2025
Q2
$708K Buy
8,121
+2,068
+34% +$175K 0.05% 272
2025
Q1
$544K Buy
6,053
+169
+3% +$15.1K 0.05% 241
2024
Q4
$470K Buy
+5,884
New +$509K 0.05% 244
2023
Q3
– Sell
-394
Closed -$34.7K – 627
2023
Q2
$34.7K Buy
+394
New +$33.9K 0.01% 360
2023
Q1
– Sell
-177
Closed -$13.8K – 560
2022
Q4
$13.8K Buy
+177
New +$14.3K ﹤0.01% 354

Other funds holding MDT

Fiduciary Alliance's MDT Position: Q3 2026 in Review

Fiduciary Alliance increased its Medtronic (MDT) stake by 276% in Q3 2026, buying an estimated $1.78M and bringing the position to 27,510 shares worth $2.37M. The position accounts for 0.18% of the portfolio, ranked #131.

Fiduciary Alliance first reported a position in MDT in Q4 2022 and has held it in 10 quarters since. 697 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Fiduciary Alliance held 27,510 shares of Medtronic worth $2.37M as of Q3 2026.
  • Fiduciary Alliance bought 20,201 Medtronic shares in Q3 2026, an estimated $1.78M.
  • Medtronic made up 0.18% of Fiduciary Alliance's portfolio in Q3 2026, its #131 holding.
  • Fiduciary Alliance first reported a position in Medtronic in Q4 2022 and has held it in 10 quarters since.
  • 697 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.